Skip to main content
. 2024 Aug 13;75:102755. doi: 10.1016/j.eclinm.2024.102755

Fig. 3.

Fig. 3

Cost-effectiveness acceptability curve. Across 1000 probabilistic sample analyses, precision surveillance became the most likely strategy to be cost-effective at willingness-to-pay thresholds exceeding $110,000/QALY gained. Universal US + AFP was cost-effective in less than 1% of PSA samples across all WTP thresholds. AFP, alpha fetoprotein; US, ultrasound.